Merck & Co., Inc. (BCBA:MRK)

Merck & Co. Ratios and Metrics

Market cap in millions ARS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	389,638,161	259,449,247	223,350,588	49,825,368	19,879,781	17,402,999
Market Cap Growth	50.56%	16.16%	348.27%	150.63%	14.23%	25.52%
Enterprise Value	422,938,304	283,776,723	244,490,775	53,232,525	21,570,896	19,207,822
Last Close Price	33060.00	22900.47	20408.79	7215.75	2924.99	1940.69
PE Ratio	14.94	14.70	756.88	19.38	14.84	29.29
PS Ratio	4.43	3.92	4.60	4.75	3.98	4.99
PB Ratio	5.48	5.43	7.34	6.11	5.06	8.15
P/TBV Ratio	19.02	30.41	-	62.26	-	-
P/FCF Ratio	21.79	13.91	30.22	19.13	20.04	35.61
P/OCF Ratio	16.66	11.72	21.24	14.73	13.72	20.21
EV/Sales Ratio	4.59	4.29	5.03	5.07	4.31	5.50
EV/EBITDA Ratio	9.25	9.45	15.35	12.38	12.35	16.78
EV/EBIT Ratio	10.85	11.06	18.93	14.67	15.12	21.97
EV/FCF Ratio	23.65	15.21	33.08	20.43	21.74	39.30
Debt / Equity Ratio	0.80	0.83	0.96	0.69	0.91	1.32
Debt / EBITDA Ratio	1.30	1.30	1.81	1.30	1.99	2.39
Debt / FCF Ratio	3.17	2.12	3.97	2.17	3.59	5.75
Asset Turnover	0.52	0.57	0.56	0.55	0.49	0.47
Inventory Turnover	2.24	2.36	2.59	2.90	2.34	2.08
Quick Ratio	1.09	0.87	0.71	0.98	0.79	0.56
Current Ratio	1.66	1.37	1.25	1.47	1.27	1.02
Return on Equity (ROE)	39.48%	40.79%	0.90%	34.46%	38.82%	17.60%
Return on Assets (ROA)	13.76%	13.90%	9.25%	11.92%	8.80%	7.38%
Return on Invested Capital (ROIC)	31.46%	31.05%	4.84%	27.92%	21.41%	17.12%
Return on Capital Employed (ROCE)	26.90%	28.10%	19.70%	24.10%	17.00%	16.20%
Earnings Yield	6.69%	6.80%	0.13%	5.16%	6.74%	3.42%
FCF Yield	4.59%	7.19%	3.31%	5.23%	4.99%	2.81%
Dividend Yield	1.66%	13.87%	11.57%	6.78%	9.13%	10.57%
Payout Ratio	42.60%	45.80%	2039.73%	48.30%	50.65%	87.94%
Buyback Yield / Dilution	0.91%	0.24%	-0.20%	-0.16%	0.12%	1.51%
Total Shareholder Return	2.57%	14.10%	11.37%	6.62%	9.25%	12.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.